News

Long-term follow-up has demonstrated that LASIK is a safe procedure even in high risk, highly myopic eyes.

OccuLogix today announced the completion of enrolment for the SOLX 790 titanium laser trabeculoplasty (TLT) clinical trial, which the firm hopes will support its application for 510(k) clearance with the FDA.

WaveLight today raised the curtain on its fine-tuned, new generation microkeratome, RONDO.

Excellent visual results can be obtained with microincision prelex in selected patients bilaterally implanted with the Acri.Lisa lens (Acri.Tec) through a 1.5 mm incision and combined with astigmatic surgery when needed.

Topical bevacizumab (Avastin) has shown excellent preliminary results and good topical tolerance when used in the prevention of corneal transplant failure.

Postoperative refraction following photorefractive keratectomy (PRK) remains stable from the second year postoperatively through to eight years.

Residual astigmatism plays an important role in the quality of visual outcome after cataract surgery, so astigmatism correction must be targeted during cataract surgery. This is especially relevant in cases over 3 D of corneal astigmatism.

Continuing on the path of IOL innovation, *Acri.Tec today unveiled the latest offering from its family of lenses in the form of the monotoric bifocal Acri.LISA Toric 466 TD lens.

Gene defect technology can be used to prevent corneal allograft rejection and the decay of endothelial cells in ex vivo corneal transplantation.

Three years of research and development paid off today when Schwind eye-tech-solutions unveiled the Schwind AMARIS excimer laser to the refractive surgery community. According to CEO Rolf Schwind, it successfully combines all available state-of-the-art technologies in one single system.

It is possible to select aspheric intraocular lenses (IOLs) based on preoperative corneal spherical aberration (SA).

An omni-focal approach, combining an aspheric prebyopic treatment with a hyperopic ablation, looks promising as a method for improving near vision in hyperopes with presbyopia.

Patients should be offered a &34;menu" of options regarding what level of discussion takes place prior to cataract surgery.

Mixing and matching the ReZoom (AMO) and Tecnis (AMO) multifocal intraocular lenses (IOLs) produces enhanced visual outcomes and patient satisfaction.

Dislocation and decentration are, overall, the most common reasons for foldable intraocular lens (IOL) explantation, and the incidence of these complications is rising.

Careful patient selection and precise biometry will all help minimise the risk of later explantation of multifocal IOLs.

Multifocal intraocular lenses (IOLs) are a good choice for the right patient.

Dual optic accommodating IOLs provide a more noticeable positive impact on a patient's quality of life than multifocal IOLs, according to Andrea Galvis and Ivan Ossma of the Instituto para Ninos Ciegos y Sordos, Columbia.

Intracameral mydriatic delivery greatly simplifies cataract surgery.

The psychological outlook of patients has enormous influence on their perception of quality of life after cataract surgery, even if the outcome is poor.

Avastin (bevacizumab) is a useful adjunct for the treatment of neovascular glaucoma, but it is too soon to say if it will have a long-term impact on glaucoma therapy.

The multifocal ReSTOR (Alcon), Tecnis multifocal (AMO) and *Acri.LISA (Acri.Tec) lenses can all provide satisfactory distance and near uncorrected vision.

Patients with Type 2 diabetes undergoing cataract surgery are twice as likely to develop macula oedema than patients without diabetes.

Unlike LASEK, LASIK significantly increases irregular astigmatism in the 3 and 5 mm central zones.

Bausch & Lomb (B&L) today launched its new Stellaris Vision Enhancement system, further demonstrating its dedication to its microincision cataract surgery franchise.

Small incision cataract surgery (SICS) is a highly desirable and effective technique for India and other countries in the eastern hemisphere because it provides a highly effective and economic treatment for the vast cataract population in that part of the world.

Antibiotic-soaked IOLs could present a viable alternative to topical antibiotics for surgeons wanting to provide a sustained release of antibiotic in cataract patients.

At one-year follow-up, the aspheric Akreos Advanced Optics (Adapt AO; Bausch & Lomb) intraocular lens (IOL) achieves better high contrast uncorrected and best corrected visual acuity (UCVA & BCVA) than the conventional spherical Akreos Adapt IOL.

The incidence of spherical aberrations tends to be lower in eyes with aspherical lenses than in eyes with spherical lenses.

When it comes to correcting spherical aberration (SA) of the whole eye, customized IOLs could be a possible approach for the future. However, if high stability of corneal asphericity during cataract surgery is required, it may be necessary to make some improvements to this approach.